Clinicopathologic Implications of Eukaryotic Initiation Factor 3f and Her‐2/neu Expression in Gastric Cancer

E-ISSN： 1752-8062|8|4|320-325

ISSN： 1752-8054

Source： CLINICAL AND TRANSLATIONAL SCIENCE (ELECTRONIC), Vol.8, Iss.4, 2015-08, pp. : 320-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Eukaryotic Initiation Factor 3f Is Associated with Prognosis in Gastric Carcinomas

Oncology Research and Treatment, Vol. 37, Iss. 4, 2014-03 ,pp. : 198-202

Karger

Access to resources Recommend Favorite

Clinicopathologic Significance of Nuclear Factor-κB and Vascular Endothelial Growth Factor Expression in Advanced Gastric Cancer Patients

Oncology Research and Treatment, Vol. 37, Iss. 4, 2014-03 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

HER2: The Neu Prognostic Marker for Breast Cancer

By Tsongalis Gregory J. Ricci Jr. Andrew

Critical Reviews in Clinical Laboratory Sciences, Vol. 38, Iss. 2, 1998-03 ,pp. : 167-182

Informa Healthcare

Access to resources Recommend Favorite

HER2/neu vaccines in breast cancer

By Khoo Steven Ponniah Sathibalan Peoples George E

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 217-223

Future Medicine

Access to resources Recommend Favorite

Targeting Her-2/neu in Breast Cancer: As Easy as This!

Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. : 150-157

Karger

Access to resources Recommend Favorite